intravesical instillation of pirarubicin in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma

intravesical instillation of pirarubicin in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma - intravesical instillation of pirarubicin in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043678

Enrollment

Registered

2021-04-01

Start date

2014-07-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urothelial carcinoma

Interventions

THP intravesical intrusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with Upper urinary tract cancer

Exclusion criteria

Exclusion criteria: patients with bladder cancer

Design outcomes

Primary

Measure	Time frame
intravesical recurrence free survival rate	—

Countries

Japan

Contacts

Public ContactKo Kobayashi

Sapporo Medical University School of Medicine Department of Urology

kou@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026